Arthur H. Amron - 14 Dec 2021 Form 4 Insider Report for NEPHROS INC (NEPH)

Role: Director
Signature: /s/ Arthur H. Amron
Issuer symbol: NEPH
Transactions as of: 14 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 16 Dec 2021, 20:16:22 UTC
Previous filing: 04 Jun 2021
Next filing: 30 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEPH	Common Stock	Award	$0	+4,582		$0.000000	4,582	14 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEPH	Stock Option (Right to Buy)	Award	$0	+7,062		$0.000000	7,062	14 Dec 2021	Common Stock	7,062	$6.82	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 14, 2021, the Company granted 4,582 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date.
F2	On December 14, 2021, the Company granted an option to purchase 7,062 shares of common stock of the Company (the "Option") in respect of the service by Mr. Amron as a member of the Board of Directors of the Company. The Option was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Option was granted to Wexford Capital LP. The Option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.

Content

On December 14, 2021, the Company granted 4,582 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date.

On December 14, 2021, the Company granted an option to purchase 7,062 shares of common stock of the Company (the "Option") in respect of the service by Mr. Amron as a member of the Board of Directors of the Company. The Option was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Option was granted to Wexford Capital LP. The Option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.